Matthew P. Kowalsky, J.D.

Matthew P. Kowalsky, J.D.

Chief Legal OfficeratEnanta Pharmaceuticals· In proxies 2022–2024

Pay in FY2024Enanta Pharmaceuticals stock -7.3% the same year

Matthew P. Kowalsky, J.D. was paid $1.5M in FY2024 (Sep). Enanta Pharmaceuticals stock fell 7.3% that year.

Pay$100 in the stock at the end of FY21 → $18
Pay is from the Summary Compensation Table of each Enanta Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Enanta PharmaceuticalsPublic company · 4 yr
    • Chief Legal Officer2022 – Present · 4 yrStock in role -79%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?